Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain Ángeles Castro; Pilar Díaz; Pere Domingo; Cristina García-Yubero; Juan E. Losa-García; Antonio Castro; Neus Vidal-Vilar; Susana Aceituno;

[Translated article] Real-world persistence with dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir-alafenamide among persons with HIV Martin-Zaragoza; Sanchez-Rubio-Ferrandez; Onteniente-Gonzalez; Gomez-Bermejo; Rodriguez-Alvarez; Alfonso Monereo-Alonso; Molina-Garcia;

Persistencia de los tratamientos con dolutegravir/lamivudina y bictegravir/emtricitabina/tenofovir-alafenamida en personas con VIH en la práctica real Martin-Zaragoza; Sanchez-Rubio-Ferrandez; Onteniente-Gonzalez; Gomez-Bermejo; Rodriguez-Alvarez; Alfonso Monereo-Alonso; Molina-Garcia;